Abstract It has been suggested that altered neurogenesis may be involved in the etiology of schizophrenia, so genes impacting on neurogenesis could be potential candidates for schizophrenia. A member of the Musashi family, the human MSI2 gene plays a substantial role in stem-cell maintenance, asymmetric division, and differentiation during neurogenesis. Our previous genome-wide association study (GWAS) implied an association of MSI2 with schizophrenia in a Han Chinese population. To further explore this association, three single-nucleotide polymorphisms (SNPs), rs9892791, rs11657292, and rs1822381, were selected for a replication study involving 921 schizophrenia cases and 1244 controls. After rigorous Bonferroni correction, two of the SNPs (rs9892791 and rs11657292) displayed significant differences in allele and genotype distribution frequencies between the case and control groups. When our GWAS and replication samples were combined, the three MSI2 SNPs were all strongly associated with schizophrenia (rs9892791: allelic P = 1.07E-5; rs11657292: allelic P = 1.95E-12; rs1822381: allelic P = 1.44E-4). These results indicate that the human MSI2 gene might be a susceptibility gene for schizophrenia and encourage future research on the functional relationship between this gene and schizophrenia.
Introduction
Abnormal neuronal development has been implicated in the etiopathogenesis of schizophrenia. The developmental disturbance, caused by genetic and environmental factors, leads to defective neuronal connectivity and biochemical functioning. Stress and maladaptation may trigger the pathological circuits later in life, resulting in the emergence of clinical symptoms [1, 2] . Neuronal development encompasses multiple processes including neurogenesis, the generation of new neurons, which is an intricate process responsible for populating the developing brain with functional neurons from neural stem cells. Aberrant neurogenesis is involved in the hippocampal volume reduction and cognitive impairment reported in schizophrenic patients [3, 4] . As a heterogeneous disorder, the risk for schizophrenia probably results from the mutual effects of many loci with small contributions [5] . Numerous identified schizophrenia susceptibility genes are indispensable in the regulation of neurogenesis [6] [7] [8] . A number of genes specifically or highly expressed in the central nervous system (CNS) have been reported to be associated with neurogenesis, and variants of these genes may participate in the onset of schizophrenia.
During the last decade, genome-wide association studies (GWAS) have become a powerful and efficient approach for investigating genetic variants associated with schizophrenia [9, 10] . In our earlier GWAS in a Han Chinese population [11] , several novel schizophrenia candidate genes were found, and among them, the Musashi2 (MSI2) gene caught our attention. MSI2 is a member of the Musashi gene family encoding an evolutionarily-conserved group of neural RNA-binding proteins [12] . Musashi was originally isolated in Drosophila as a molecule required for the asymmetric division of sensory organ precursor cells [13] . Since then, Musashi family genes have been identified and cloned in various species. In mammals, two family members, MSI1 and MSI2, have been identified [14, 15] . The expression of human Musashi is developmentally regulated in neural precursor cells, including CNS stem cells in the subventricular zone and dentate gyrus of the hippocampus where neurogenesis occurs [16] . Some neurodevelopmental factors have been identified as the targets of Musashi proteins [17] . The human MSI2 gene has been mapped to chromosome 17q, a potential susceptibility region for schizophrenia [18] . To verify the association between the human MSI2 gene and schizophrenia in the Han Chinese population, a replication association study involving three SNPs of MSI2 was performed in an independent sample of 921 schizophrenia cases and 1244 healthy controls.
Methods and Materials Participants
In the present replication association study, 921 schizophrenia patients (449 males and 472 females; mean age, 29.3 ± 9.8 years) and 1244 healthy controls (597 males and 647 females; mean age, 29.6 ± 8.7 years) were included. All participants were Han Chinese from the same region of northern China and unrelated to the previous GWAS samples. The patients were all recruited from the Institute of Mental Health, Peking University, Beijing, China. Consensus diagnoses were made by at least two experienced psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. None of the patients had severe medical complications. Healthy controls were selected by a simple non-structured interview, excluding individuals with a history of mental health problems or neurological diseases. The healthy controls were matched with the patients for age, gender, and ethnicity. Approval for the current study was obtained from the Ethics Committee of the Institute of Mental Health, Peking University. After informing the participants or guardians of the objectives and procedures of the current study, written informed consent was obtained.
SNP Selection
The MSI2 gene spans [400 kb in the human genome (Fig. 1A) , and our previous GWAS included 229 SNPs in and around the human MSI2 gene region (Fig. 1B) . Information on these SNPs was downloaded from the International HapMap project database (http://hapmap.ncbi.nlm. nih.gov/). Linkage disequilibrium (LD) blocks were determined using Haploview version 4.1. Three SNPs (rs9892791, rs11657292, and rs1822381) with significant association with schizophrenia in our previous GWAS were selected for replication analysis. All three SNPs were in MSI2 introns.
Sample Preparation and Genotyping
Peripheral blood samples were collected from all participants, and genomic DNA was extracted using a commercially-available QIAamp DNA Mini kit (Qiagen, Hilden, Germany). 0 ) were designed to amplify the three DNA fragments containing the three selected MSI2 SNPs using Oligo6.0 software (MBI Inc., Norwalk, USA). The PCR amplification was performed as previously described [6] . Briefly, PCR was performed in a 25-mL volume containing 10 mmol/L Tris-HCL (pH 8.3), 50 mmol/L KCl, 1.5 mmol/L MgCl 2 , 200 mmol/L of each dNTP, 0.25 mmol/L of each primer, 1 U of Taq DNA polymerase, and 40 ng genomic DNA. The conditions used for PCR amplification were initial denaturation at 94°C for 5 min, followed by 36 cycles at 94°C for 30 s, 58-62°C for 30 s, and 72°C for 40 s, and a final elongation at 72°C for 7 min. PCR products were purified using a BigDye Terminator Cycle Sequencing Ready Reaction kit, and then either completely digested with 4 U of restriction enzyme overnight followed by agarose gel electrophoresis (2-3% gel) stained with ethidium bromide, or sequenced on an ABI PRISM 377-96 DNA Sequencer (Applied Biosystems, New York, USA).
Statistics
Deviation of the genotypes from Hardy-Weinberg equilibrium was tested using a v 2 goodness-of-fit test. The distribution of gender and the difference of age between cases and controls were evaluated using Pearson's v 2 -test and Student's t-test with SPSS 16.0 (SPSS Inc., Chicago, IL). Statistical differences in allelic distribution between patients and controls were evaluated by Pearson's v 2 -test. Pairwise LD between any two alleles was evaluated using the D 0 value. Odds ratios (ORs) and their 95% confidence intervals (95% CI) were calculated to evaluate the effect of different alleles. These analyses were performed using Haploview version 4.1 (http://www.broad.mit.edu/mpg/ haploview/) [19] and SHEsis [20] software (http://analysis. bio-x.cn/SHEsisMain.htm). The statistical power of our first sample size was calculated using the genetic power calculator (http://pngu.mgh.harvard.edu/*purcell/gpc/cc2.html) [21] . The joint analytical power of the combined sample was calculated using the Power Calculator for Two Stage Association Studies (http://www.sph.umich.edu/csg/abe casis/CaTS/) [22] . The Bonferroni correction was applied for multiple tests analyzing independent variables in order to control inflation of the type I error rate according to an effective number of independent marker loci. Results were considered significant at two-tailed P \ 0.05.
Results and Discussion

GWAS Analysis
Two-hundred-twenty-nine MSI2 SNPs were included in our previous GWAS. Pairwise LD was computed between each pair of SNPs in the control sample using the criterion D 0 [ 0.8 (Fig. 1B) . According to the GWAS results, only one SNP (rs11657292) reached genome-wide significance (P = 2.31E-6, v 2 = 22.368, OR 0.69, 95% CI 0.59-0.81), but we also considered four SNPs (rs9892791, rs11654639, rs1822381, and rs7504077) with P \ 0.05 (Table 1) . 
Replication Study
From these five SNPs, three (rs9892791, rs11657292, and rs1822381) from different LD blocks (Table 2) were selected based on the initial GWAS results and the HapMap information on the Han Chinese in Beijing population, and genotyped in 921 patients with schizophrenia and 1244 healthy controls for the replication association study. The independent case-control sample-set had *80% power to detect allele frequency differences assuming an OR of 1.5 with a minor allele frequency of 0.1. None of the genotype distributions of the three SNPs in cases and controls deviated from Hardy-Weinberg equilibrium (Table S1 ). The genotype and allele distribution frequencies of all SNPs in the case and control groups are shown in Table 3 . The significant differences in both genotype and allele distribution frequencies remained for rs9892791 (allelic P = 0.00108, v 2 = 10.690, OR 0.69, 95% CI 0.55-0.86; genotypic P = 0.00436, v 2 = 10.879) and rs11657292 (allelic P = 6.84E-5, v 2 = 15.881, OR 0.74, 95% CI 0.64-0.86; genotypic P = 4.02E-4, v 2 = 15.664). After rigorous Bonferroni correction, significance remained for both SNPs.
Combined Sample Analysis
We combined the data from the current replication study and the previous GWAS (Table 4 ). The joint analytical power of the combined sample reached 80%. After combination, the three SNPs all had a strong association with schizophrenia (rs9892791: P = 1.07E-5, v 2 = 19.419, OR 0.70, 95% CI 0.59-0.82; rs11657292: P = 1.95E-12, v 2 = 49.786, OR 0.68, 95% CI 0.61-0.76; rs1822381: P = 1.44E-4, v 2 = 14.471, OR 0.85, 95% CI 0.76-0.92). For most biomedical diseases including schizophrenia, the results of association studies are inconsistent and unrepeatable. In this study, a replication association analysis was performed for the human MSI2 gene, a novel candidate gene identified from our previous GWAS [11] , in an independent sample of 921 cases and 1244 controls from the Han Chinese population. We chose three SNPs (rs9892791, rs11657292, and rs1822381) from different LD blocks and found a significant association between two SNPs and schizophrenia. Rs11657292, which the only SNP reaching genome-wide significance in our GWAS, showed the most significant association with schizophrenia. To obtain stronger statistical evidence, a combined analysis of the replication study and GWAS data was performed and indicated that the human MSI2 gene is involved in the development of schizophrenia. We also downloaded genotyping data from the 1000 Genome Project [23] . Individuals from five East Asian populations (Han Chinese in Beijing, Japanese in Tokyo, Southern Han Chinese, Chinese Dai in Xishuangbanna, and Kinh in Ho Chi Minh City) were used to identify linkage SNPs for the three schizophrenia-associated SNPs (rs9892791, rs11657292, and rs1822381). A total of 12 SNPs were identified as linkage SNPs (r 2 [ 0.8) ( Table 5 ). Several of these SNPs have a significant cis-eQTL effect for the MSI2 gene [24] ( Table 6 ), indicating that different variants of the three schizophrenia-associated SNPs may affect the expression level of MSI2.
The human MSI2 gene is located on chromosome 17q in a potential susceptibility region for schizophrenia [18] . A genome-wide linkage study of age-at-onset in schizophrenia indicated a peak LOD score on marker D17S787, which is close to the MSI2 locus [25] . As a conserved RNA-binding protein, MSI2 is strongly expressed in neural precursor cells residing in the subventricular zone [15] that are subjected to the refined process of cellfate specification during neurogenesis, which requires the post-transcriptional spatiotemporal regulation of the proteome by RNA-binding proteins. RNA-binding proteins can package specific mRNAs within ribonucleoprotein granules and target specific fragments of mRNAs to adjust the expression of functionally-related genes [26] . Despite the unclear targets of MSI2, it has been hypothesized that MSI2 may bind uridine-rich RNA sequences similar to MSI1 in vivo [15] . Msi2-silencing experiments in mouse Msi1 -/-neural stem cells revealed functional redundancy and cooperation of Msi1 and Msi2 in the regulation of proliferation and maintenance of a neural stem cell population [27] . However, the human MSI1 gene displayed no significant association with schizophrenia (Table S2 and Fig. S1 ). The reason for this association difference is unknown, and further functional exploration of these two genes may provide an explanation.
The expression of the MSI2 gene is rapidly down-regulated in newly-generated postmitotic neurons, with the exception of GABAergic parvalbumin (PV)-containing interneurons in the neocortex and hippocampus [27] . Alterations in cortical GABAergic interneurons are thought to be pivotal in the pathology of schizophrenia as concluded from a series of postmortem studies [28, 29] . GABAergic interneurons are core components of the corticolimbic circuitry. They provide both inhibitory and disinhibitory modulation of cortical and hippocampal circuits and contribute to the generation of oscillatory rhythms, to discriminative information processing, and to the gating of sensory information within the corticolimbic system. All of these functions are abnormal in schizophrenia [30] . PVcontaining GABAergic interneurons comprise a GABAergic interneuron subclass that is essential for the synchronization of neuronal activity [31] , and the activity of PV-containing GABAergic interneurons has been linked to the production of cortical network oscillations [32] . Activation of PVcontaining GABAergic interneurons via the N-methyl D-aspartate receptor (NMDAR) has been suggested to be a crucial element in the NMDAR hypofunction hypothesis of schizophrenia [33] . The wiring of PV-containing GABAergic interneurons is strongly modulated by the neuregulin signaling pathway which numerous genetic linkage and association studies indicate is involved in a high risk of schizophrenia [34] . So, apart from its role in neural stem cells and neuronal development, MSI2 may be involved in the maintenance of proper functioning of PV-containing GABAergic interneurons by controlling the local translation or stability of mRNAs that encode essential neurotransmitters, receptors, and channels. MSI2 is also expressed in the stem-cell compartments of other tissues and in aggressive tumors as well as playing a broad role in stemness and the determination of cell fate [35] [36] [37] [38] [39] . The detailed action of MSI2 on physiological and pathological processes requires further research.
In conclusion, although it is unclear if and how the SNPs influence transcription of the MSI2 gene, our association study suggests that the MSI2 gene may be considered to be a risk gene for schizophrenia. Additional studies are required to elucidate the involvement of these SNPs in the regulation of MSI2 gene transcription before we can confirm the potential role of MSI2 in the pathogenesis of schizophrenia; moreover, multiple prospective studies in other ethnic populations are needed to confirm the results of our analysis. MAF minor allele frequency, CI confidence interval. a 746 patients with schizophrenia and 1599 healthy controls included in the previous GWAS [11] .
b Minor allele/major allele. 
